What is it about?

Bupropion is a commonly used antidepressant. Drug-induced aseptic meningitis is a rare cause of inflammation of the brain and spinal cord. This paper describes FDA's evaluation of bupropion-induced aseptic meningitis, focusing on a key patient case. This evaluation led to FDA requesting changes to the package inserts (i.e., prescribing information) for medicines that contain bupropion to advise healthcare professionals of the potential risk. The term "aseptic meningitis" was added to the list of Adverse Reactions in the labels.

Featured Image

Why is it important?

This report communicates FDA's scientific findings in greater detail that was is allowed in an update to the bupropion-containing product package inserts, serving as a resource for healthcare professionals.

Read the Original

This page is a summary of: Bupropion-Induced Aseptic Meningitis: Postmarketing Safety Evaluation and Case Report, Psychopharmacology Bulletin, October 2026, MedWorks Media,
DOI: 10.64719/pb.21591.
You can read the full text:

Read

Contributors

The following have contributed to this page